Preventing Antibiotic-Associated DiarRhea Using Erceflora

Bacillus Clausii in Preventing Antibiotic-Associated Diarrhea Among Filipino Infant and Children: A Multi-Center, Randomized, Open-Label Controlled (Treatment vs No Treatment) Clinical Trial of Efficacy and Safety

To determine the effectiveness of the pre-biotic Bacillus clausii in preventing antibiotic associated diarrhea among hospitalized immunocompetent Filipino children.

Inclusion Criteria:

• Clinically stable children with mild to moderate illness admitted for treatment of bacterial infection.

Exclusion Criteria:

• Children with unstable medical condition
• In any form of immunocompromized state
• With contraindication to take medication
• Has taken antibiotics for 3 weeks before start of trial.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.